You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INCB018424

Showing 51 - 57 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (Ruxolitinib, Placebo)

Completed
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +111 more
Feb 12, 2018

Breast Cancer Trial in Boston (Ruxolitinib)

Terminated
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jan 3, 2017

Leukemia Trial in Houston (Ruxolitinib)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2019

Myelofibrosis Trial in Worldwide (Ruxolitinib, Best Available Therapy (BAT))

Completed
Has Results
  • Myelofibrosis
  • Innsbruck, Austria
  • +60 more
Jul 11, 2019

Rheumatoid Arthritis Trial in Poland, United States (INCB018424, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • INCB018424
  • Placebo
  • Huntsville, Alabama
  • +14 more
Mar 9, 2015

Myelofibrosis Trial in Scottsdale, Winter Park, Houston (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Scottsdale, Arizona
  • +2 more
Feb 5, 2014

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • ruxolitinib phosphate
  • +2 more
  • Birmingham, Alabama
  • +23 more
Oct 22, 2014